Clinical Trial Update: A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for brodalumab in axial spondyloarthritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Axial Spondyloarthritis | Phase 3 | Status: COMPLETED